Showing results (4691-4700 of 5,673) with videos related to

Sort By:
Pageof 568
Lupus|October 11, 2018
Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosusF B Vincent, R Kandane-Rathnayake, A Y Hoi, et al.
Lupus|October 11, 2018
GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosusY M Mosaad, A Hammad, A A Elghzaly, et al.
Lupus|March 28, 2022
Retrobulbar blood flow velocity in systemic lupus erythematosus assessed by color Doppler imagingKang Xue, Tingting Guo, Boya Lei, et al.
Lupus|March 28, 2022
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activityAmanda M Eudy, Bryce B Reeve, Theresa Coles, et al.
Lupus|March 22, 2022
Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experienceSung Soo Ahn, Juyoung Yoo, Sang-Won Lee, et al.
Lupus|March 7, 2022
The relationship between serum A proliferation-inducing ligand and B-cell activating factor levels with disease activity and organ involvement in systemic lupus erythematosusSelma Sari, Suzan Cinar, Yasemin Yalcinkaya, et al.
Lupus|April 20, 2022
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic reviewElizabeth Ross, Khalid Abulaban, Elizabeth Kessler, et al.
Lupus|March 14, 2000
Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markersH Amano, S Morimoto, H Kaneko, et al.
Lupus|March 14, 2000
Dermatomyositis and polymyositis associated with the antiphospholipid syndrome-a novel overlap syndromeY Sherer, A Livneh, Y Levy, et al.
Lupus|March 14, 2000
Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosusM Mukai, T Bohgaki, A Notoya, et al.
Pageof 568